"Nigella sativa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A plant genus of the family RANUNCULACEAE that contains alpha-hederin, a triterpene saponin in the seeds, and is the source of black seed oil.
| Descriptor ID |
D031881
|
| MeSH Number(s) |
B01.650.940.800.575.912.250.838.518.750
|
| Concept/Terms |
Nigella sativa- Nigella sativa
- Nigella sativas
- sativa, Nigella
- Black Cumin
- Black Cumins
- Cumins, Black
- Cumin, Black
- Kalonji
- Kalonjus
|
Below are MeSH descriptors whose meaning is more general than "Nigella sativa".
Below are MeSH descriptors whose meaning is more specific than "Nigella sativa".
This graph shows the total number of publications written about "Nigella sativa" by people in this website by year, and whether "Nigella sativa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Nigella sativa" by people in Profiles.
-
Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19. Pharm Biol. 2021 Dec; 59(1):696-703.
-
The role of thymoquinone, a major constituent of Nigella sativa, in the treatment of inflammatory and infectious diseases. Clin Exp Pharmacol Physiol. 2021 11; 48(11):1445-1453.
-
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial. Complement Ther Med. 2021 Sep; 61:102769.
-
In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity. Vascul Pharmacol. 2021 06; 138:106856.
-
Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies. Molecules. 2021 Feb 25; 26(5).
-
The Popularity of the Biologically-Based Therapies During Coronavirus Pandemic Among the Google Users in the USA, UK, Germany, Italy and France. Complement Ther Med. 2021 May; 58:102682.
-
In Silico Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of Nigella Sativa. Curr Drug Discov Technol. 2021; 18(4):570-573.
-
Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review. Curr Pharm Biotechnol. 2021; 22(4):444-450.
-
Tutankhamun's Antimalarial Drug for Covid-19. Drug Res (Stuttg). 2021 Jan; 71(1):4-9.
-
Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure. Phytother Res. 2021 Mar; 35(3):1329-1344.